Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Bullboard Posts
Post by GoBio14on Jan 29, 2014 7:09am
206 Views
Post# 22145904

Interesting buying

Interesting buying
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 28/14 Jan 28/14 Boland, Christopher John Direct Ownership Common Shares 10 - Acquisition in the public market 100,000 $0.060
Jan 23/14 Jan 20/14 Groome, Cameron Lionel Indirect Ownership Common Shares 10 - Acquisition in the public market 30,000 $0.065
Jan 23/14 Jan 20/14 Groome, Cameron Lionel Indirect Ownership Common Shares 10 - Acquisition in the public market 30,000 $0.065
Jan 23/14 Jan 20/14 Groome, Cameron Lionel Indirect Ownership Common Shares 10 - Acquisition in the public market 150,000 $0.065
Jan 8/14 Jan 8/14 Groome, Cameron Lionel Indirect Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 19,000 $0.070
Dec 11/13 Dec 11/13 Groome, Cameron Lionel Indirect Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 19,000 $0.070
Nov 14/13 Nov 13/13 Groome, Cameron Lionel Indirect Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 18,000 $0.075
Oct 15/13 Oct 9/13 Groome, Cameron Lionel Indirect Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 14,000 $0.085
Sep 26/13 Aug 28/13 Burton, Graham William Indirect Ownership Common Shares 90 - Change in the nature of ownership 125,384 $0.070
Sep 26/13 Aug 28/13 Burton, Graham William Indirect Ownership Common Shares 90 - Change in the nature of ownership -12,042 $0.070
Sep 26/13 Aug 28/13 Burton, Graham William Direct Ownership Common Shares 90 - Change in the nature of ownership

Bullboard Posts